Abstract | BACKGROUND/AIM: MATERIALS AND METHODS:
YM155, a suppressor of survivin, siRNA, and immunoblot were used to examine the role of survivin in osimertinib-resistance. The effect of drugs on cell viability in vitro was examined by trypan blue staining. The in vivo effects of drugs on tumor growth were examined using a xenograft mouse model. RESULTS: CONCLUSION:
|
Authors | Tomomi Sanomachi, Shuhei Suzuki, Keita Togashi, Shizuka Seino, Takashi Yoshioka, Chifumi Kitanaka, Masashi Okada, Masahiro Yamamoto |
Journal | Anticancer research
(Anticancer Res)
Vol. 39
Issue 9
Pg. 4817-4828
(Sep 2019)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 31519584
(Publication Type: Journal Article)
|
Copyright | Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. |
Chemical References |
- Acrylamides
- Aniline Compounds
- Protein Kinase Inhibitors
- Quinolones
- RNA, Small Interfering
- Survivin
- Thiophenes
- brexpiprazole
- osimertinib
- EGFR protein, human
- ErbB Receptors
|
Topics |
- Acrylamides
(pharmacology)
- Aniline Compounds
(pharmacology)
- Animals
- Apoptosis
(drug effects)
- Cell Line, Tumor
- Cell Survival
(drug effects)
- Disease Models, Animal
- Drug Resistance, Neoplasm
(genetics)
- ErbB Receptors
(antagonists & inhibitors)
- Humans
- Male
- Mice
- Neoplastic Stem Cells
(drug effects, metabolism)
- Protein Kinase Inhibitors
(pharmacology)
- Quinolones
(pharmacology)
- RNA, Small Interfering
(genetics)
- Survivin
(genetics)
- Thiophenes
(pharmacology)
- Xenograft Model Antitumor Assays
|